CDKN2A and neoplasm: Especially for LUSC, a comprehensive study of 178 LUSC specimens revealed that significant alteration in CDKN2A and RB1 gene was identified in 72% of LUSC cases, and CDK4/6 gene was frequently amplified in CDKN2A intact tumor [7,8].